Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Kramer

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Fetal Diagnosis and Therapy|January 16, 1998
Concordance for cloacal dysgenesisR L Kramer, M P Johnson, F Qureshi, et al.
Fetal Diagnosis and Therapy|June 12, 1999
Amnioinfusion in the evaluation of fetal obstructive uropathy: the effect of antibiotic prophylaxis on complication ratesB Feldman, S Hassan, R L Kramer, et al.
Fetal Diagnosis and Therapy|July 3, 1998
Pastoral care utilization among women electing pregnancy termination for fetal anomaliesT B Brady, S Lidums, Y Yaron, et al.
Fetal Diagnosis and Therapy|January 16, 1998
Differences in measurements of the atria of the lateral ventricle: does gender matter?R L Kramer, Y Yaron, M P Johnson, et al.
American Journal of Medical Genetics|February 6, 1999
Molecular cytogenetic analysis of a de novo 5q31q33 deletion associated multiple congenital anomalies: case reportR L Kramer, B Feldman, S A Ebrahim, et al.
Obstetrics and Gynecology|March 1, 1997
A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacyR L Kramer, G J Gilson, D S Morrison, et al.
Human Reproduction (Oxford, England)|October 2, 1998
Selective termination and elective reduction in twin pregnancies: 10 years experience at a single centreY Yaron, K D Johnson, P K Bryant-Greenwood, et al.
Fetal Diagnosis and Therapy|January 16, 1998
No effect of fetal sex on amniotic fluid alpha-fetoproteinA Drugan, Y Yaron, J Murphy, et al.
American Journal of Obstetrics and Gynecology|October 16, 1999
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcomeY Yaron, M Cherry, R L Kramer, et al.
American Journal of Medical Genetics|October 27, 1998
Determinants of parental decisions after the prenatal diagnosis of Down syndromeR L Kramer, R K Jarve, Y Yaron, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Fetal Diagnosis and Therapy|January 16, 1998
Concordance for cloacal dysgenesisR L Kramer, M P Johnson, F Qureshi, et al.
Fetal Diagnosis and Therapy|June 12, 1999
Amnioinfusion in the evaluation of fetal obstructive uropathy: the effect of antibiotic prophylaxis on complication ratesB Feldman, S Hassan, R L Kramer, et al.
Fetal Diagnosis and Therapy|July 3, 1998
Pastoral care utilization among women electing pregnancy termination for fetal anomaliesT B Brady, S Lidums, Y Yaron, et al.
Fetal Diagnosis and Therapy|January 16, 1998
Differences in measurements of the atria of the lateral ventricle: does gender matter?R L Kramer, Y Yaron, M P Johnson, et al.
American Journal of Medical Genetics|February 6, 1999
Molecular cytogenetic analysis of a de novo 5q31q33 deletion associated multiple congenital anomalies: case reportR L Kramer, B Feldman, S A Ebrahim, et al.
Obstetrics and Gynecology|March 1, 1997
A randomized trial of misoprostol and oxytocin for induction of labor: safety and efficacyR L Kramer, G J Gilson, D S Morrison, et al.
Human Reproduction (Oxford, England)|October 2, 1998
Selective termination and elective reduction in twin pregnancies: 10 years experience at a single centreY Yaron, K D Johnson, P K Bryant-Greenwood, et al.
Fetal Diagnosis and Therapy|January 16, 1998
No effect of fetal sex on amniotic fluid alpha-fetoproteinA Drugan, Y Yaron, J Murphy, et al.
American Journal of Obstetrics and Gynecology|October 16, 1999
Second-trimester maternal serum marker screening: maternal serum alpha-fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcomeY Yaron, M Cherry, R L Kramer, et al.
American Journal of Medical Genetics|October 27, 1998
Determinants of parental decisions after the prenatal diagnosis of Down syndromeR L Kramer, R K Jarve, Y Yaron, et al.
Pageof 4